All In Biotech

Free tool

FAERS Monitor: Humatrope

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 019640 or its brand name (Humatrope, Somatropin). Reports on generic versions are filed under their own applications.

Reports

11,846

Serious

6,001

51% of reports

Hospitalization

2,327

Death reported

475

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • incorrect dose administered1,016
  • injection site pain643
  • off label use511
  • headache481
  • drug dose omission431
  • fatigue424
  • underdose407
  • device leakage342
  • malaise325
  • wrong technique in product usage process260
  • drug ineffective244
  • drug dose omission by device222
  • nausea221
  • injection site bruising219
  • pyrexia209

Reports by year received

View as table
YearReports
2004148
2005161
2006156
2007212
2008197
2009350
2010277
2011327
2012388
2013197
2014272
20152,473
2016575
2017531
2018622
2019782
2020710
2021440
2022538
2023854
2024798
2025505
2026333

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,313 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device leakageSignal34214.112.74,128
underdoseSignal4079.99.03,260
incorrect dose administeredSignal1,0167.97.56,190
drug dose omission by deviceSignal2225.04.4717
injection site bruisingSignal2194.94.3673
drug dose omissionSignal4314.64.21,233
injection site painSignal6433.73.51,297
wrong technique in product usage processSignal2602.32.0187
headache4811.41.247
malaise3251.31.225
pyrexia2091.10.91
off label use5111.01.01
fatigue4241.00.90
nausea2210.50.4117
drug ineffective2440.30.3356

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.